サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541219

免疫グロブリン市場レポート：製品、用途、送達様式、地域別、2024年～2032年

Immunoglobulin Market Report by Product, Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Disease, Myasthenia Gravis, and Others), Mode of Delivery, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 140 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.72円
免疫グロブリン市場レポート：製品、用途、送達様式、地域別、2024年～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の免疫グロブリン市場規模は2023年に157億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに249億米ドルに達し、2024年から2032年の間に5.1%の成長率（CAGR）を示すと予測しています。

抗体としても知られる免疫グロブリンは、血漿または白血球（WBC）によって産生される糖タンパク質分子の一群を指します。免疫グロブリンは一般に血清中および免疫系の細胞内に存在し、細菌やウイルスなどの抗原を明確に認識して結合し、その破壊を助けることで抗体として機能します。これらの検査は、医師が免疫不全、アレルギー、若年性特発性関節炎、ループス、セリアック病などの自己免疫疾患を診断するのに役立ちます。現在、免疫グロブリンは、生物学的特徴、構造、標的特異性、分布の違いにより、様々なクラスが世界中で利用可能です。

免疫グロブリン市場動向：

急速な都市化と多忙なスケジュールのため、個人の間でファーストフードの消費が増加しています。これは、座りがちなライフスタイルや、多発性骨髄腫、ワルデンシュトレーム・マクログロブリン血症、自己免疫疾患などの病状を抱える患者の増加とともに、市場の成長を促す主な要因の1つとなっています。さらに、早期診断に対する意識の高まりや、個別化医療に対する嗜好の高まりが、市場の成長に寄与しています。さらに、免疫グロブリンはさまざまな投与経路を通じて、身体がさまざまな感染症と闘うのを助ける。その結果、コロナウイルス感染症（COVID-19）の入院患者数が増加し、パンデミックの拡大を防ぐための効果的な治療法が急務となっていることから、高免疫グロブリンは感染症管理に効果的な医薬品として活用されています。これとは別に、複数の製薬会社が神経疾患の治療のために、効率を改善した新しい免疫グロブリンを発表しています。研究開発（R&D）プロジェクトへの資金提供の増加やヘルスケアインフラの改善といったその他の要因も、今後数年間の市場成長をさらに促進すると予想されます。

本レポートで扱う主な質問

  • 2023年の世界の免疫グロブリン市場の市場規模は？
  • 2024-2032年の世界の免疫グロブリン市場の予想成長率は？
  • 世界の免疫グロブリン市場を牽引する主要因は何か？
  • 世界の免疫グロブリン市場に対するCOVID-19の影響は？
  • 世界の免疫グロブリン市場の用途別内訳は？
  • 免疫グロブリン市場の納入形態別の内訳は？
  • 免疫グロブリン市場の世界における主要地域は？
  • 世界の免疫グロブリン市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の免疫グロブリン市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • IgG
    • 市場動向
    • 市場予測
  • 免疫グロブリンA
    • 市場動向
    • 市場予測
  • IgM
    • 市場動向
    • 市場予測
  • IgE
    • 市場動向
    • 市場予測
  • 免疫グロブリンD
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 低ガンマグロブリン血症
    • 市場動向
    • 市場予測
  • 慢性炎症性脱髄性多発神経炎（CIDP）
    • 市場動向
    • 市場予測
  • 免疫不全疾患
    • 市場動向
    • 市場予測
  • 重症筋無力症
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：送達様式別

  • 静脈内投与法
    • 市場動向
    • 市場予測
  • 皮下投与法
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • ADMA Biologics Inc.
    • Baxter international Inc.
    • Biotest AG
    • CSL Limited
    • Grifols S.A
    • Kedrion S.p.A
    • LFB SA
    • Octapharma AG
    • Sanquin Plasma Products B.V.
    • Takeda Pharmaceutical Company Limited
図表

List of Figures

  • Figure 1: Global: Immunoglobulin Market: Major Drivers and Challenges
  • Figure 2: Global: Immunoglobulin Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Immunoglobulin Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Immunoglobulin Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Immunoglobulin Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Immunoglobulin Market: Breakup by Mode of Delivery (in %), 2023
  • Figure 7: Global: Immunoglobulin Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Immunoglobulin (IgG) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Immunoglobulin (IgG) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Immunoglobulin (IgA) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Immunoglobulin (IgA) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Immunoglobulin (IgM) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Immunoglobulin (IgM) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Immunoglobulin (IgE) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Immunoglobulin (IgE) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Immunoglobulin (IgD) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Immunoglobulin (IgD) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Immunoglobulin (Hypogammaglobulinemia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Immunoglobulin (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Immunoglobulin (Immunodeficiency Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Immunoglobulin (Immunodeficiency Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Immunoglobulin (Myasthenia Gravis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Immunoglobulin (Myasthenia Gravis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Immunoglobulin (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Immunoglobulin (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Immunoglobulin (Intravenous Mode of Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Immunoglobulin (Intravenous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Immunoglobulin Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Immunoglobulin Industry: SWOT Analysis
  • Figure 82: Global: Immunoglobulin Industry: Value Chain Analysis
  • Figure 83: Global: Immunoglobulin Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunoglobulin Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Immunoglobulin Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Immunoglobulin Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Immunoglobulin Market Forecast: Breakup by Mode of Delivery (in Million US$), 2024-2032
  • Table 5: Global: Immunoglobulin Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Immunoglobulin Market: Competitive Structure
  • Table 7: Global: Immunoglobulin Market: Key Players
目次
Product Code: SR112024A4505

The global immunoglobulin market size reached US$ 15.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.

Also known as antibodies, immunoglobulins refer to a class of glycoprotein molecules produced by plasma or white blood cells (WBCs). They are generally present in the serum and cells of the immune system and function as antibodies by explicitly recognizing and binding antigens, such as bacteria or viruses, and aiding in their destruction. Their tests help doctors diagnose immunodeficiencies, allergies, and autoimmune conditions like juvenile idiopathic arthritis, lupus, and celiac disease. At present, different classes of immunoglobulins are available around the world depending on biological features, structure, target specificity, and distribution.

Immunoglobulin Market Trends:

Due to rapid urbanization and hectic schedules, there is a rise in the consumption of fast food among individuals. This, along with sedentary lifestyles and the increasing number of patients with medical conditions like multiple myeloma, Waldenstrom macroglobulinemia, and autoimmune disorders, represents one of the primary factors impelling the growth of the market. Additionally, rising awareness about early diagnosis and the increasing preferences for personalized medicines are contributing to market growth. Moreover, immunoglobulins through a variety of routes of administration help the body fight various infectious diseases. As a result, with the rising number of hospitalized patients with coronavirus disease (COVID-19) and an urgent need for effective therapies to prevent the spread of the pandemic, hyperimmune globulin is utilized as an effective medicine in managing the infection. Apart from this, several pharmaceutical companies are introducing new and advanced immunoglobulins with improved efficiency for the treatment of neurological disorders. Other factors, such as increasing funding for research and development (R&D) projects and the improving healthcare infrastructure are anticipated to propel the market growth further in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunoglobulin market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and mode of delivery.

Breakup by Product:

IgG

IgA

IgM

IgE

IgD

Breakup by Application:

Hypogammaglobulinemia

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Immunodeficiency Disease

Myasthenia Gravis

Others

Breakup by Mode of Delivery:

Intravenous Mode of Delivery

Subcutaneous Mode of Delivery

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics Inc., Baxter international Inc., Biotest AG, CSL Limited, Grifols S.A, Kedrion S.p.A, LFB SA, Octapharma AG, Sanquin Plasma Products B.V. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report

  • 1. What was the size of the global immunoglobulin market in 2023?
  • 2. What is the expected growth rate of the global immunoglobulin market during 2024-2032?
  • 3. What are the key factors driving the global immunoglobulin market?
  • 4. What has been the impact of COVID-19 on the global immunoglobulin market?
  • 5. What is the breakup of the global immunoglobulin market based on the application?
  • 6. What is the breakup of the global immunoglobulin market based on the mode of delivery?
  • 7. What are the key regions in the global immunoglobulin market?
  • 8. Who are the key players/companies in the global immunoglobulin market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunoglobulin Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 IgG
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 IgA
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 IgM
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 IgE
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 IgD
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Hypogammaglobulinemia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunodeficiency Disease
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Myasthenia Gravis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Mode of Delivery

  • 8.1 Intravenous Mode of Delivery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Subcutaneous Mode of Delivery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 ADMA Biologics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Baxter international Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biotest AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 CSL Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Grifols S.A
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Kedrion S.p.A
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 LFB SA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Octapharma AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Sanquin Plasma Products B.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Takeda Pharmaceutical Company Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis